Request Demo
Last update 29 Mar 2025
THDBH120
Last update 29 Mar 2025
Overview
Basic Info
Drug Type Synthetic peptide |
Synonyms THDBH-120 |
Target |
Action agonists |
Mechanism GIPR agonists(Gastric inhibitory polypeptide receptor agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
5
Clinical Trials associated with THDBH120CTR20242389
在中国肥胖受试者中评价注射用THDBH120多次给药的安全性、耐受性、药代动力学特征和初步有效性的随机、双盲、安慰剂对照的Ib期临床试验
[Translation] A randomized, double-blind, placebo-controlled Phase Ib clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of multiple doses of THDBH120 for injection in obese Chinese subjects
CTR20241940
在中国成人2型糖尿病患者中评价注射用THDBH120多次给药的安全性、耐受性、药代动力学和药效动力学的随机、双盲、安慰剂对照的Ib期临床试验
[Translation] A randomized, double-blind, placebo-controlled Phase Ib clinical trial to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of THDBH120 for injection in Chinese adults with type 2 diabetes
NCT06744868
A Single- and Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of THDBH120 Injection in Healthy Subjects: A Randomized, Bouble-Blind, Placebo-Controlled Phase I Trial
100 Clinical Results associated with THDBH120
Login to view more data
100 Translational Medicine associated with THDBH120
Login to view more data
100 Patents (Medical) associated with THDBH120
Login to view more data
100 Deals associated with THDBH120
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Obesity | Phase 2 | China | 05 Dec 2024 | |
| Diabetes Mellitus, Type 2 | Phase 1 | China | 19 Dec 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
CTR20241940 (NEWS) Manual  | Phase 1 | - | kdqkxlgrvq(cwwedtiosi) = iiifnktqid vmweeejqpp (hwcmrwihns ) View more | Positive | 27 Feb 2025 | ||
Placebo | - | ||||||
Phase 1 | - | THDBH120 1-1-2-4mg每周一次给药 | pyuazszuzj(agivxpfvtd) = THDBH120在超重或肥胖受试者中展现出良好的安全性与耐受性。 avmylmwrfz (owqmddbrug ) Met | Positive | 11 Feb 2025 | ||
THDBH120 2-4-6mg每两周一次给药 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free